Kumiko Hosono, Miyako Hoshino. Real‐World Safety and Effectiveness of Icatibant in Patients With Hereditary Angioedema (HAE): Post‐Marketing Surveillance in Japan. // Journal of Dermatology. – 2026. – DOI: 10.1111/1346-8138.70447. – URL: https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.70447?af=R
Kumiko Hosono & Miyako Hoshino (2026). Real‐World Safety and Effectiveness of Icatibant in Patients With Hereditary Angioedema (HAE): Post‐Marketing Surveillance in Japan. Journal of Dermatology. https://doi.org/10.1111/1346-8138.70447
Kumiko Hosono and Miyako Hoshino. “Real‐World Safety and Effectiveness of Icatibant in Patients With Hereditary Angioedema (HAE): Post‐Marketing Surveillance in Japan.” Journal of Dermatology, 2026. doi:10.1111/1346-8138.70447.
@article{Hosono2026,
title = {Real‐World Safety and Effectiveness of Icatibant in Patients With Hereditary Angioedema (HAE): Post‐Marketing Surveillance in Japan},
author = {Hosono, Kumiko and Hoshino, Miyako},
journal = {Journal of Dermatology},
year = {2026},
doi = {10.1111/1346-8138.70447},
url = {https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.70447?af=R}
}